Overview

Evaluation Of The Ability Of Fesoterodine To Increase Urethral Pressure In Stress Urinary Incontinence Patients

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The hypothesis under evaluation is that fesotorodine may provide clinical benefit in the treatment of the condition of stress urinary incontinence
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer
Treatments:
Fesoterodine